GIUNCHI, VALENTINA
GIUNCHI, VALENTINA
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Assegnisti
A pharmacological view on accounting for pharmacokinetic factors in the estimation of pharmaceutical emissions based on drug usage data
2025 Klont, Frank; Bellinga, J. Stein; Giunchi, Valentina; Balafas, Spyros; Hak, Eelko
Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency
2025 Giunchi, Valentina; Fusaroli, Michele; Cangini, Agnese; Fortinguerra, Filomena; Zito, Simona; Pierantozzi, Andrea; Lunghi, Carlotta; Poluzzi, Elisabetta; Trotta, Francesco
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health: Pharmaceutical Residues in the Environment: Threats to Ecosystems and Human Health
2024 Lunghi, C.; Valetto, M. R.; Caracciolo, A. B.; Bramke, I.; Caroli, S.; Bottoni, P.; Castiglioni, S.; Crisafulli, S.; Cuzzolin, L.; Deambrosis, P.; Giunchi, V.; Grisotto, J.; Marcomini, A.; Moretti, U.; Murgia, V.; Pandit, J.; Polesello, S.; Poluzzi, E.; Romizi, R.; Scarpa, N.; Scroccaro, G.; Sorrentino, R.; Sundström, A.; Wilkinson, J.; Paolone, G.
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS
2024 Fusaroli M.; Giunchi V.; Battini V.; Puligheddu S.; Khouri C.; Carnovale C.; Raschi E.; Poluzzi E.
Environmental sustainability-an essential component of rational use of medicines
2024 Giunchi, V; Fusaroli, M; Linder, E; Villén, J; Raschi, E; Lunghi, C; Wettermark, B; Poluzzi, E; Nekoro, M
Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase
2024 Noseda, R.; Bedussi, F.; Giunchi, V.; Fusaroli, M.; Raschi, E.; Ceschi, A.
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System
2024 Fusaroli, M.; Polizzi, S.; Menestrina, L.; Giunchi, V.; Pellegrini, L.; Raschi, E.; Weintraub, D.; Recanatini, M.; Castellani, G.; De Ponti, F.; Poluzzi, E.
Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors
2023 Sisi, Monia; Vitale, Giovanni; Fusaroli, Michele; Riefolo, Mattia; Giunchi, Valentina; D’Errico, Antonietta; Ardizzoni, Andrea; Raschi, Emanuel; Gelsomino, Francesco
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach
2023 Giunchi, Valentina; Fusaroli, Michele; Hauben, Manfred; Raschi, Emanuel; Poluzzi, Elisabetta
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System
2023 Fusaroli M.; Pelletti G.; Giunchi V.; Pugliese C.; Bartolucci M.; Necibi E.N.; Raschi E.; De Ponti F.; Pelotti S.; Poluzzi E.
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study
2023 Fusaroli M.; Giunchi V.; Battini V.; Gringeri M.; Rimondini R.; Menchetti M.; Radice S.; Pozzi M.; Nobile M.; Clementi E.; De Ponti F.; Carnovale C.; Raschi E.; Poluzzi E.
L’impatto ambientale dei farmaci sulle acque superficiali e la sua stima attraverso i dati di utilizzo
2023 Valentina Giunchi
The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies
2023 Giunchi V.; Fusaroli M.; Linder E.; Villén J.; Wettermark B.; Nekoro M.; Raschi E.; Lunghi C.; Poluzzi E.
Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System
2022 Raschi E.; Fusaroli M.; Giunchi V.; Repaci A.; Pelusi C.; Mollica V.; Massari F.; Ardizzoni A.; Poluzzi E.; Pagotto U.; Di Dalmazi G.
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System
2022 Fusaroli M.; Raschi E.; Giunchi V.; Menchetti M.; Rimondini Giorgini R.; De Ponti F.; Poluzzi E.
Post-marketing safety profile of cannabis products: Signals from the FDA adverse event reporting system
2022 Giunchi, V; Fusaroli, M; Lunghi, C; Zongo, A; Raschi, E; Poluzzi, E
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People
2022 Lunghi C.; Trevisan C.; Fusaroli M.; Giunchi V.; Raschi E.; Sangiorgi E.; Domenicali M.; Volpato S.; De Ponti F.; Poluzzi E.
What Is the Safety Profile of Cannabis-Based Medications? Analysis of the Post-Marketing Signals from the FDA Adverse Event Reporting System
2022 Lunghi, C; Fusaroli, M; Giunchi, V; Raschi, E; Zongo, A; Poluzzi, E